Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1323

Aug 30, 2020

FRAMOS Launches an Industrial 3D GigE Camera Based on Intel’s® RealSense™ Technology

Posted by in categories: biotech/medical, robotics/AI

FRAMOS, the global partner for Vision Technologies, has developed an industrial grade version of Intel’s® RealSense™ Suite to provide Gigabit Ethernet connectivity and an IP66 rated housing. The D435e industrial 3D GigE Vision camera leverages the advantages of easy-to-integrate 3D vision in rugged environments; enabling real-time positioning, orientation and tracking of robots, automated guided vehicles, and smart machines.

Christopher Scheubel, Product Manager for Intel at FRAMOS, says: “Providing an ethernet solution in combination with Intel’s® RealSense™ Technology is key to enabling 3D vision applications for industry that require longer cable lengths, dust and water resistance, and locked connections. Applications like robotic pick and place systems, automated guided vehicles (AGVs), retail observation, or automatic patient positioning, benefit from the very robust implementation and high usability.”

Aug 30, 2020

A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes

Posted by in categories: biotech/medical, electronics

BACKGROUND

A closed-loop system of insulin delivery (also called an artificial pancreas) may improve glycemic outcomes in children with type 1 diabetes.

METHODS

Continue reading “A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes” »

Aug 30, 2020

Coronavirus cases surpass 25 million as pandemic strains nations around the world

Posted by in category: biotech/medical

The number of reported Covid-19 cases across the globe has surpassed 25 million, with the U.S., Brazil and India leading the grim count, according to data from Johns Hopkins University.

The coronavirus has killed more than 843,000 people worldwide since it emerged from Wuhan, China, late last year, with the Americas reporting the bulk of fatalities. The U.S., Mexico and Brazil represent more than 40% of the global death toll, according to Johns Hopkins.

Continue reading “Coronavirus cases surpass 25 million as pandemic strains nations around the world” »

Aug 30, 2020

What A Nasal Spray Vaccine Against COVID-19 Might Do Even Better Than A Shot

Posted by in category: biotech/medical

Preventing the spread of the disease is also important, and vaccines delivered by nasal spray may do that.

Aug 30, 2020

House to vote on removing cannabis from list of controlled substances

Posted by in categories: biotech/medical, law

The House will vote on legislation next month to remove cannabis from the Controlled Substances Act and erase some marijuana criminal records.

The bill would not legalize the drug, which would be left up to states, but the vote will still be a historic step in the effort to reduce legal penalties related to the drug. House Majority Whip James Clyburn (D-S.C.) said in an email to members that the vote will take place during the September work period.

BREAKING: The U.S. House will vote on a bill to remove cannabis from the Controlled Substances Act.

Aug 30, 2020

As the Pandemic Drags on, More People Are Smoking More Weed

Posted by in category: biotech/medical

Dealers are struggling to keep up, and particularly in Australia.

Aug 30, 2020

We Can Now See Inside the Human Body With the Greatest Detail To Date

Posted by in category: biotech/medical

This laser technology can see inside our bodies like never before 🤯.

Aug 30, 2020

“Jumping” DNA Regulates Human Neurons

Posted by in categories: biotech/medical, neuroscience

Summary: Transposable elements team up with evolutionary recent neurons to influence differentiation and physiological function of neurons in brain development.

Source: EPFL

The human genome contains over 4.5 million sequences of DNA called “transposable elements”, these virus-like entities that “jump” around and help regulate gene expression. They do this by binding transcription factors, which are proteins that regulate the rate of transcription of DNA to RNA, influencing gene expression in a broad range of biological events.

Aug 30, 2020

Young cancer survivors show genetic signs of accelerated aging

Posted by in categories: biotech/medical, genetics, life extension

A striking new study has found young cancer survivors show high expression of a gene known to be an effective marker of aging. The researchers suggest this genetic biomarker could be used to identify cancer survivors most at risk of later-life frailty due to their treatment.

As we age, concentrations of a gene called p16INK4a gradually increase in our cells, making it a potentially useful molecular marker for aging. One of the gene’s roles is to slow cell division and reduce the proliferation of stem cells.

In a new study researchers set out to investigate p16INK4a levels in pediatric and young adult cancer survivors. The hypothesis was that increased p16INK4a levels could be an effective sign of frailty among young cancer survivors.

Aug 30, 2020

IBM has built a new drug-making lab entirely in the cloud

Posted by in categories: biotech/medical, health, robotics/AI

The news: IBM has built a new chemistry lab called RoboRXN in the cloud. It combines AI models, a cloud computing platform, and robots to help scientists design and synthesize new molecules while working from home.

How it works: The online lab platform allows scientists to log on through a web browser. On a blank canvas, they draw the skeletal structure of the molecular compounds they want to make, and the platform uses machine learning to predict the ingredients required and the order in which they should be mixed. It then sends the instructions to a robot in a remote lab to execute. Once the experiment is done, the platform sends a report to the scientists with the results.

Why it matters: New drugs and materials traditionally require an average of 10 years and $10 million to discover and bring to market. Much of that time is taken up by the laborious repetition of experiments to synthesize new compounds and learn from trial and error. IBM hopes that a platform like RoboRXN could dramatically speed up that process by predicting the recipes for compounds and automating experiments. In theory, it would lower the costs of drug development and allow scientists to react faster to health crises like the current pandemic, in which social distancing requirements have caused slowdowns in lab work.